My pick for this qtr is Amylin Pharmaceuticals (AMLN). Like Joe, i took a look at our portfolio and tried a to pick a stock that was in a different sector than what we already have. I settled on AMLN because of the type of drugs they manufacturer and the amount they currently have on the market. These guys focus almost all of their resources on the treatment of obesity and diabetes in the US. Which as anyone will tell you, is a growing problem in the US. The market for these drugs is only going to increase.
Now, normally i don't like to pick a stock that i know very little about the industry, but we already have GE and CX in our profile, which are more my bag.
These guys sell "BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection for the treatment of patients with Type II diabetes. The company also has research and development programs in the therapeutic areas of diabetes and obesity."
They have 2 approved drugs and various other drugs in mutiple stages of approval. They seem to have money in the bank as well.
Even if its too early to pull the trigger on a pharmie, i at least want to get the discussion rolling about them and see what all of your thoughts are regarding drug companies.
No comments:
Post a Comment